SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-22-008983
Filing Date
2022-05-10
Accepted
2022-05-10 16:15:47
Documents
54
Period of Report
2022-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q prds-20220331.htm   iXBRL 10-Q 1797099
2 EX-31.1 prds-ex31_1.htm EX-31.1 16300
3 EX-31.2 prds-ex31_2.htm EX-31.2 16519
4 EX-32.1 prds-ex32_1.htm EX-32.1 7301
5 EX-32.2 prds-ex32_2.htm EX-32.2 7474
  Complete submission text file 0000950170-22-008983.txt   5141122

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT prds-20220331.xsd EX-101.SCH 58862
7 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT prds-20220331_lab.xml EX-101.LAB 431046
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT prds-20220331_cal.xml EX-101.CAL 26842
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT prds-20220331_pre.xml EX-101.PRE 320224
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT prds-20220331_def.xml EX-101.DEF 186854
48 EXTRACTED XBRL INSTANCE DOCUMENT prds-20220331_htm.xml XML 440127
Mailing Address 2173 SALK AVENUE SUITE 250, PMB#052 CARLSBAD CA 92008
Business Address 2173 SALK AVENUE SUITE 250, PMB#052 CARLSBAD CA 92008 415-649-8758
PARDES BIOSCIENCES, INC. (Filer) CIK: 0001822711 (see all company filings)

IRS No.: 852696306 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-40067 | Film No.: 22909814
SIC: 2834 Pharmaceutical Preparations